DOW JONES27,960.80-1031.61 -3.56%
S&P 5003,225.89-111.86 -3.35%
NASDAQ9,221.28-355.31 -3.71%

SVB Leerink Maintains Outperform on Abeona Therapeutics, Announces $6 Price Target

SVB Leerink analyst Mani Foroohar maintains Abeona Therapeutics (NASDAQ:ABEO) with a Outperform and announces $6 price target.

Benzinga · 02/10/2020 14:51

SVB Leerink analyst Mani Foroohar maintains Abeona Therapeutics (NASDAQ:ABEO) with a Outperform and announces $6 price target.